ABSTRACT
BACKGROUND: Proximal renal tubulopathy was reported in Australian dogs with markedly increased frequency from September 2007. METHODS: Two veterinarian-completed surveys were launched in response to an increased incidence of acquired proximal renal tubulopathy in dogs. The selection criterion for inclusion was glucosuria with blood glucose < 10 mmol/L. Data collected included signalment, presenting signs, history of feeding treats, results of urinalysis and blood tests, treatment and time to resolution of clinical signs. RESULTS: A total of 108 affected dogs were studied. All had been fed the same brand of dried chicken treats, made in China, for a median of 12 weeks (range, 0.3-78 weeks). Small breeds (< 10 kg) accounted for 88% of cases. Common presenting signs included polyuria/polydipsia (76%), lethargy (73%), inappetence (65%) and vomiting (54%). Common biochemical findings included euglycaemia (74%; 71/96), hypoglycaemia (23%; 22/96), acidosis (77%; 20/26), hypokalaemia (45%; 38/84), hypophosphataemia (37%; 28/75) and azotaemia (27%; 23/85). In addition to discontinuation of treats, 64 dogs received medical treatment, including intravenous fluids (52%) and oral electrolyte, amino acid or vitamin supplements. Six dogs died or were euthanased. Two dogs were necropsied. Histopathological findings consisted of proximal tubular necrosis accompanied by regeneration. Time to resolution of clinical signs in 35 survivors available for follow-up was < 2 weeks (n = 8), 2-4 weeks (n = 2), 5-7 weeks (n = 5) and 2-6 months (n = 10). CONCLUSION: Of the 108 dogs with acquired proximal renal tubulopathy contemporaneous with chicken treat consumption, most survived but many required aggressive supportive care. The treats likely contained a toxin targeting the proximal renal tubules. Diet history and urinalysis were vital for diagnosis.
Subject(s)
Dog Diseases/pathology , Kidney Tubules, Proximal/pathology , Animal Feed/adverse effects , Animals , Blood Glucose/analysis , Dog Diseases/etiology , Dogs , Female , Hypokalemia/veterinary , Hyponatremia/veterinary , Hypophosphatemia/veterinary , Male , Retrospective Studies , Surveys and QuestionnairesABSTRACT
OBJECTIVE: To establish reference values for activated coagulation time (ACT) in normal cats and dogs, by visual assessment of clot formation using the MAX-ACT(TM) tube. SUBJECTS: We recruited 43 cats and 50 dogs for the study; 11 cats and 4 dogs were excluded from the statistical analysis because of abnormalities on clinical examination or laboratory testing including anaemia, prolonged prothrombin time (PT) or activated partial thromboplastin time (APTT), or insufficient plasma volume for comprehensive laboratory coagulation testing. PROCEDURE: Blood samples were collected via direct venipuncture for MAX-ACT, packed cell volume/total solids, manual platelet estimation and PT/APTT measurement. Blood (0.5 mL) was mixed gently in the MAX-ACT tube at 37 degrees C for 30 s, then assessed for clot formation every 5 to 10 s by tipping the tube gently on its side and monitoring for magnet movement. The endpoint was defined as the magnet lodging in the clot. The technique was tested with 10 dogs by collecting two blood samples from the same needle insertion and running a MAX-ACT on each simultaneously. RESULTS: In normal cats the mean MAX-ACT was 66 s (range 55-85 s). In normal dogs the mean was 71 s (range 55-80 s). There was no statistical difference between the first and second samples collected from the same needle insertion. CONCLUSIONS: and Clinical Relevance In both cats and dogs, a MAX-ACT result >85 s should be considered abnormal and further coagulation testing should be performed. Additionally, failure to discard the first few drops of the sample does not appear to significantly affect results.
Subject(s)
Blood Coagulation/physiology , Cats/blood , Dogs/blood , Animals , Female , Hematocrit/veterinary , Male , Partial Thromboplastin Time/veterinary , Platelet Count/veterinary , Prothrombin Time/veterinary , Reference Values , Statistics, NonparametricABSTRACT
Generalised paresis, severe hypokalaemia and kaliuresis, metabolic alkalosis and hypertension, characteristic of mineralocorticoid excess, were identified in a dog with hyperadrenocorticism due to a functional adrenocortical carcinoma. Aldosterone concentration was decreased and deoxycorticosterone concentration increased in the presence of hypokalaemia. These metabolic abnormalities resolved with resection of the carcinoma. Mineralocorticoid excess in dogs with hyperadrenocorticism is generally considered to be of little clinical significance but resulted in the acute presentation of this patient. The possible pathogenesis of mineralocorticoid excess in this case of canine hyperadrenocorticism is discussed.
Subject(s)
Adrenocortical Hyperfunction/veterinary , Dog Diseases/diagnosis , Hypertension/veterinary , Adrenocortical Hyperfunction/complications , Adrenocortical Hyperfunction/diagnosis , Alkalosis/etiology , Alkalosis/veterinary , Animals , Blood Chemical Analysis/veterinary , Diagnosis, Differential , Dog Diseases/blood , Dog Diseases/diagnostic imaging , Dogs , Female , Hypertension/etiology , Hypokalemia/etiology , Hypokalemia/veterinary , Ultrasonography , Urinalysis/veterinaryABSTRACT
A 1-year-old male Boxer dog presented with sustained supraventricular tachycardia and tachycardia-induced cardiomyopathy. Conversion to sinus rhythm was achieved initially with intravenous lignocaine and subsequently with oral procainamide. Oral procainamide treatment was relatively successful in maintaining normal sinus rhythm with no side effects apart from a reversible change in coat colour. Electrophysiological studies demonstrated the presence of an accessory pathway connecting the right atrium to the right ventricle and confirmed the diagnosis of orthodromic atrioventricular reciprocating tachycardia. Radiofrequency catheter ablation of the accessory pathway led to permanent resolution of the supraventricular tachycardia and for 9.5 years the dog has had no further signs of cardiac disease. The successful treatment of this condition highlights the importance of differentiating tachycardia-induced cardiomyopathy from dilated cardiomyopathy.
Subject(s)
Cardiomyopathies/veterinary , Cardiomyopathy, Dilated/veterinary , Catheter Ablation/veterinary , Dog Diseases/diagnosis , Tachycardia, Supraventricular/veterinary , Animals , Cardiomyopathies/diagnosis , Cardiomyopathies/etiology , Cardiomyopathies/surgery , Cardiomyopathy, Dilated/diagnosis , Cardiomyopathy, Dilated/surgery , Catheter Ablation/methods , Diagnosis, Differential , Dog Diseases/surgery , Dogs , Electrocardiography/veterinary , Male , Tachycardia, Supraventricular/complications , Tachycardia, Supraventricular/diagnosis , Tachycardia, Supraventricular/surgery , Treatment OutcomeABSTRACT
Death adder envenomation is rare in humans and there is only one brief report previously in dogs. This paper details three cases of canine common death adder (Acanthophis antarcticus) envenomation and one case of bardick (Echiopsis curta) envenomation which were responsive to death adder antivenom. The available literature on death adder envenomations is also reviewed. The main clinical sign in the four dogs was severe lower motor neuron paralysis. There was no clinical evidence of coagulopathy or myopathy. Use of a snake venom detection kit was essential for selection of appropriate antivenom. Death adder and bardick envenomation in dogs potentially has a good prognosis if sufficient antivenom is administered and intensive supportive care is available.
Subject(s)
Antivenins/therapeutic use , Elapid Venoms/antagonists & inhibitors , Elapid Venoms/poisoning , Snake Bites/veterinary , Animals , Australia , Female , Male , Prognosis , Reagent Kits, Diagnostic , Snake Bites/therapy , Species Specificity , Treatment OutcomeABSTRACT
OBJECTIVE: To determine the distribution of A/B blood types in pedigree and crossbred cats in the Sydney region, and to estimate the associated risk of administering incompatible blood in an unmatched random transfusion. DESIGN: A prospective/retrospective study of blood specimens collected from both sick and healthy cats. MATERIALS AND METHODS: Blood was collected from 355 cats from the Sydney region over a 12-year period from 1992 to 2003. Specimens were obtained from 187 domestic crossbred cats (short and long-haired) and 168 pedigree cats. The blood type of each cat was determined by one of three different laboratories using standard methods that varied over the duration of the survey. RESULTS: The distributions of blood types obtained by the three laboratories were not significantly different. The prevalence of type-A, type-B and type-AB blood types in crossbred cats was 62%, 36% and 1.6%, respectively. This is the highest percentage of type-B cats so far reported for an outbred population of domestic cats, and is significantly higher than the 26% reported previously for cats in the Brisbane region. The calculated frequency for the type-B allele assuming Hardy-Weinberg equilibrium for this feline population is 0.60; the corresponding frequency of the type-A allele is thus approximately 0.40. The calculated proportion of random transfusions from this population giving rise to an incompatible blood transfusion is 46%, with half of these being life-threatening events. The calculated proportion of random matings from this population at risk for developing neonatal isoerythrolysis is 23%. The distribution of A and B blood types for pedigree cats was in general agreement with data reported previously for cats in North America and Europe, suggesting that the distribution of blood types in these purebred populations is relatively consistent throughout the world. CONCLUSIONS: The prevalence of type B cats in the owned domestic and pedigree cat population is so high that blood typing or cross matching prior to transfusion should be mandatory, except in Siamese/Oriental cats.
Subject(s)
ABO Blood-Group System/genetics , Cats/blood , Animals , Female , Male , New South Wales/epidemiology , Pedigree , Prevalence , Prospective Studies , Retrospective StudiesABSTRACT
Twenty-one lower respiratory tract infections diagnosed in cats at University of Sydney Veterinary Centre between 1995 and 2000 were identified retrospectively. Patient records were analysed to determine historical, clinical, clinicopathologic and radiographic features of lower respiratory tract infections. Response to therapy was also assessed. Infectious agents identified were Mycoplasma spp., Pasteurella spp., Bordetella bronchiseptica, Salmonella typhimurium, Pseudomonas sp., Mycobacterium thermoresistible, Cryptococcus neoformans, Toxoplasma gondii, Aelurostrongylus abstrusus and Eucoleus aerophilus. The study provides a detailed retrospective analysis of infectious lower respiratory tract disease in this population of cats.
Subject(s)
Cat Diseases/epidemiology , Cat Diseases/microbiology , Pneumonia, Bacterial/veterinary , Animals , Anti-Bacterial Agents/therapeutic use , Bronchodilator Agents/therapeutic use , Cat Diseases/therapy , Cats , Female , Male , New South Wales/epidemiology , Pneumonia, Bacterial/epidemiology , Pneumonia, Bacterial/microbiology , Records/veterinary , Retrospective StudiesABSTRACT
A retrospective study of 88 bronchoalveolar lavage specimens from 80 cats presenting to the University of Sydney Veterinary Centre between 1995 and 2000 was performed. Bronchoalveolar lavage cytology and microbiology in conjunction with other diagnostic aids and patient records were used to classify cases as lower respiratory tract infections (LTRIs), LRTI revisits, feline bronchial disease, cardiac disease, neoplastic disease and multisystemic disease. Cases for which a definitive diagnosis could not be made were classified as inconclusive. Infectious agents identified were Mycoplasma spp., Pasteurella spp., Bordetella bronchiseptica, Salmonella typhimurium, Pseudomonas sp., Cryptococcus neoformans, Aelurostrongylus abstrusus and Eucoleus aerophilus. The study highlights the importance of bronchoalveolar lavage cytology and microbiology in the evaluation of feline lower respiratory tract disease.
Subject(s)
Bronchoalveolar Lavage Fluid/cytology , Cat Diseases/diagnosis , Cat Diseases/epidemiology , Respiratory Tract Diseases/veterinary , Animals , Cat Diseases/microbiology , Cat Diseases/parasitology , Cats , Female , Male , Microbiology , New South Wales/epidemiology , Predictive Value of Tests , Records/veterinary , Respiratory Tract Diseases/diagnosis , Respiratory Tract Diseases/epidemiology , Retrospective StudiesABSTRACT
Twenty-five cases of feline bronchial disease were identified retrospectively. The criteria for inclusion were consistent clinical signs or histopathology and no other identifiable aetiology. Patient records were analysed to determine historical, clinical, clinicopathologic and radiographic features. The main presenting complaints were coughing and dyspnoea. The most common physical finding was dyspnoea. The majority of radiographs had a bronchial pattern either as the sole change or as a component of a mixed pattern. Bronchoalveolar lavage cytology was neutrophilic or eosinophilic in the majority of cats. There was no association between age, breed, sex, clinical signs, bronchoalveolar lavage cytology or radiographic severity and disease severity.
Subject(s)
Bronchitis/veterinary , Cat Diseases/epidemiology , Animals , Bronchitis/epidemiology , Bronchoalveolar Lavage/veterinary , Cat Diseases/diagnostic imaging , Cat Diseases/etiology , Cat Diseases/pathology , Cat Diseases/therapy , Cats , Female , Male , New South Wales/epidemiology , Radiography , Records/veterinary , Retrospective StudiesSubject(s)
Anaplasmataceae Infections/veterinary , Anaplasmataceae/genetics , Cat Diseases/epidemiology , Cat Diseases/microbiology , RNA, Ribosomal, 16S/genetics , Anaplasmataceae/isolation & purification , Anaplasmataceae Infections/epidemiology , Anaplasmataceae Infections/microbiology , Animals , Base Sequence , Cats , DNA Primers , Molecular Sequence Data , Polymerase Chain Reaction/veterinary , Western Australia/epidemiologyABSTRACT
Spontaneous hepatic rupture, secondary to the accumulation of hepatic amyloid, was diagnosed in six cats over a two-year period. Previous reports of feline hepatic amyloidosis have documented clusters of cases from breeding catteries. Most affected cats have been Siamese or a related breed and the disease is generally regarded as familial. In contrast, the cases presented here were sporadic, with relatives and other cats in the household not clinically affected. They included a Devon rex, a breed not previously reported with this condition, and a domestic shorthair. Clinical signs in three of these cases had, prior to referral, been misinterpreted as resulting from blunt trauma, immune-mediated haemolysis or a coagulopathy. Antemortem diagnostic features, including new data on the value of hepatic ultrasonography and fine-needle aspirate cytology, are reported. These cases illustrate how the course of this disease can vary between individuals and that, despite the dramatic underlying pathology, hepatic amyloidosis can present a diagnostic challenge and should be suspected in any young adult cat with consistent clinical signs, irrespective of breed or environment.
Subject(s)
Amyloidosis/veterinary , Cat Diseases/pathology , Liver Diseases/veterinary , Amyloidosis/pathology , Animals , Cats , Female , Liver Diseases/pathology , Male , Rupture/veterinaryABSTRACT
Three young Shar-Pei dogs were presented for signs of an acute widespread dermatopathy associated with fever and malaise. Cutaneous lesions initially consisted of multifocal areas of skin discolouration (haemorrhagic papules, macules or plaques) or oedema, preferentially affecting the head and limbs. In some locations, pus-filled bullae were evident also. Cutaneous lesions exuded seropurulent liquid and, in time, usually progressed to full thickness necrosis and ulceration. Lesions were so widespread and severe that one of the dogs was euthanased because its owners could not afford the reconstructive surgery required to close the skin deficits left at the completion of otherwise successful therapy. Histological examination of representative biopsies showed neutrophilic dermatitis and vasculitis, which ultimately resulted in ischaemic necrosis of skin. Therapy with immunosuppressive doses of corticosteroids, and in one case cyclophosphamide, resulted in prompt amelioration of the underlying inflammatory process, although regions of skin deprived of their blood supply eventually became necrotic and sloughed. Healing occurred through granulation, contraction and epithelialisation. The physical findings in these three dogs were so similar that it is likely all suffered from the same breed-related syndrome, an immune-mediated vasculitis precipitated by some event, such as vaccination or an undetected infection. Whatever the inciting cause, it was most likely a one-off event, as the two surviving dogs were readily weaned off immunosuppressive medication without relapse.
Subject(s)
Dog Diseases/diagnosis , Vasculitis/veterinary , Adrenal Cortex Hormones/therapeutic use , Animals , Animals, Newborn , Breeding , Cyclophosphamide/therapeutic use , Diagnosis, Differential , Dog Diseases/drug therapy , Dog Diseases/pathology , Dogs , Female , Fever/complications , Fever/veterinary , Immunosuppressive Agents/therapeutic use , Lameness, Animal/etiology , Male , Neutrophil Infiltration , Vasculitis/complications , Vasculitis/diagnosisABSTRACT
Gastroduodenal ulceration (GU) and blood loss was diagnosed in eight cats and compared with 25 previously reported cases of feline GU. Cats with GU presented in a critical condition. Clinical signs consistent with gastrointestinal bleeding were infrequently identified although anaemia was a common finding. Non-neoplastic causes of feline GU tended to have a shorter clinical course with ulcers confined to the stomach. Conversely, cats with tumour-associated GU usually had a more protracted clinical course, weight loss, and ulcers located in the stomach for gastric tumours and the duodenum for extra-intestinal tumours. In this series, definitive diagnosis was possible for cats with neoplasia (gastric tumours and gastrinoma), however, it was difficult to precisely identify the underlying aetiology in cats with non-neoplastic GU. Prompt stabilisation with a compatible blood transfusion, surgical debridement or resection, antibiotic and antiulcer therapy, and treatment of the underlying disease, if identified, was successful in the majority of cases. The prognosis for cats with appropriately managed GU depended on the underlying aetiology, but even cats with neoplasia could be successfully palliated for prolonged periods.
Subject(s)
Cat Diseases/diagnosis , Gastrointestinal Hemorrhage/veterinary , Peptic Ulcer/veterinary , Animals , Anti-Bacterial Agents/therapeutic use , Anti-Ulcer Agents/therapeutic use , Blood Transfusion/veterinary , Cat Diseases/drug therapy , Cat Diseases/pathology , Cat Diseases/surgery , Cats , Diagnosis, Differential , Emergency Treatment/veterinary , Female , Gastrointestinal Hemorrhage/complications , Gastrointestinal Hemorrhage/therapy , Male , Peptic Ulcer/complications , Peptic Ulcer/diagnosisSubject(s)
Brain Diseases/veterinary , Cat Diseases/diagnosis , Cryptococcosis/veterinary , Granuloma/veterinary , Animals , Antigens, Fungal/analysis , Brain/microbiology , Brain/pathology , Brain Diseases/diagnosis , Brain Diseases/microbiology , Cat Diseases/microbiology , Cats , Cryptococcosis/diagnosis , Cryptococcosis/microbiology , Diagnosis, Differential , Granuloma/diagnosis , Granuloma/microbiology , Magnetic Resonance Imaging/veterinary , Seizures/microbiology , Seizures/veterinaryABSTRACT
OBJECTIVE: A form of autosomal dominant polycystic kidney disease has been identified in Persian cats and related breeds. Two features make elimination of this disease from future generations an achievable goal: the autosomal dominant mode of inheritance and the availability of a noninvasive technique, renal ultrasonography, to identify affected cats. The aims of this study were; to determine the prevalence of the disease in Persian cats and related breeds in Sydney and Brisbane, to determine any effect of domicile and breed on disease prevalence, to alert veterinary practitioners to the prevalence of autosomal dominant polycystic kidney disease and to propose methods of eliminating the disease from future generations of cattery-bred cats. DESIGN: To be included in this scheme, cats had to be of Persian or related breed and be older than 10 months-of-age. Younger cats were excluded because of the increased likelihood of a false negative result. Renal ultrasonography was performed using either a Medison 600 with a 7.5 MHz mechanical sector scanner (n = 228, Brisbane) or using an ATL UltraMark-9 with a 5 to 10 MHz linear array transducer (n = 92, Sydney). The effects of domicile (Sydney versus Brisbane) and breed on the prevalence of autosomal dominant polycystic kidney disease were tested using two-tailed Fisher's Exact tests. RESULTS: A total of 320 cats were tested comprising 230 Persians, 48 Himalayans, 17 Exotics, 14 Burmillas, 6 Ragdolls and 5 Chinchillas. The prevalence of autosomal dominant polycystic kidney disease in Sydney (45%) and Brisbane (42%) was comparable and no sex predilection was identified. The disease was not detected in Ragdolls, although only a small number was tested. Two of 14 Burmilla cats were positive (14%), demonstrating that long hair coat and brachycephalic features do not segregate with the polycystic kidney disease trait. CONCLUSION: These results show that the prevalence of autosomal dominant polycystic kidney disease amongst purebred, long-haired cats in Australia is currently very high. Ultrasound detection schemes are easy to establish and breeder participation can be encouraged through subsidisation.
Subject(s)
Cat Diseases/epidemiology , Kidney/diagnostic imaging , Polycystic Kidney, Autosomal Dominant/veterinary , Animals , Breeding , Cat Diseases/diagnostic imaging , Cats , Female , Male , New South Wales/epidemiology , Polycystic Kidney, Autosomal Dominant/diagnostic imaging , Polycystic Kidney, Autosomal Dominant/epidemiology , Prevalence , Queensland/epidemiology , UltrasonographyABSTRACT
OBJECTIVE: To determine the response of Australian cats with lymphosarcoma to chemotherapy and/or surgery in relation to patient and tumour characteristics, haematological and serum biochemical values and retroviral status. DESIGN: Prospective study of 61 client-owned cats with naturally-occurring lymphosarcoma subjected to multi-agent chemotherapy and/or surgery. PROCEDURE: An accepted chemotherapy protocol utilising l-asparaginase, vincristine, cyclophosphamide, doxorubicin, methotrexate and prednisolone was modified and used to treat 60 cats with lymphosarcoma. Clinical findings were recorded before and during therapy. As far as practical, cases were followed to death, euthanasia or apparent cure. Owner satisfaction with the results of chemotherapy was determined using a questionnaire sent after the completion of chemotherapy. RESULTS: One cat, with lymphosarcoma limited to a single mandibular lymph node, was treated using surgery alone and was cured. The other 60 cats were treated using multi-agent chemotherapy, although seven cats with localised intestinal, ocular and subcutaneous lesions had these lesions partially (2 intestinal lesions) or completely (2 eyes, 2 intestinal lesions and a cluster of regional lymph nodes) resected prior to starting chemotherapy. The median survival time for these 60 cats was 116 days. Of the 60 cats, 48 rapidly went into complete remission following the administration of 1-asparaginase, vincristine and prednisolone (complete remission rate 80%) and these cats had a median survival of 187 days. Three cats were censored from further analysis as their long-term survival data were uninterpretable because they died of causes unrelated to lymphosarcoma or were prematurely lost to follow-up. Twenty cats were classed as 'long-term survivors' based on survival time in excess of one year and at least 14 were 'cured' based on the absence of physical evidence of lymphosarcoma 2-years after initiating treatment. In other words, of the 48 cats that reached complete remission, in excess of 29% were 'cured'. Despite detailed analysis, few meaningful prognostic indicators based on patient or tumour characteristics were identified, although long-term survivors were more likely to be less than 4-years (P= 0.04) and to have tumours of the T-cell phenotype (P= 0.06). Excluding the one FeLV ELISA-positive cat with mediastinal LSA, 7 of 9 cats less than 4 years-of-age were long-term survivors (median survival time >1271 days). There was a strong association between achieving complete remission and long-term survival (P = 0.003). On the basis of 27 replies to a questionnaire, owners were generally very satisfied with the response to chemotherapy, irrespective of the survival time of the individual patient. Eighty five percent of owners expressed complete satisfaction with their decision to pursue chemotherapy and 70% believed their cat's health status improved during the first 2-weeks of treatment. Importantly, 78% of owners considered that chemotherapy required a very substantial time commitment on their part. CONCLUSIONS: It was possible to cure approximately one quarter of cats with lymphosarcoma using sequential multi-agent chemotherapy and/or surgery. FeLV-negative cats younger than 4 years (typically with mediastinal lymphosarcoma) had a particularly favourable prognosis. The decision to embark on chemotherapy should be based on the results of induction chemotherapy with l-asparaginase, vincristine and prednisolone, as the response to this was a good predictor of long-term survival. Cats surviving the first 16 weeks of chemotherapy generally enjoyed robust remissions (in excess of 1 year) or were cured of their malignancy.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cat Diseases/drug therapy , Cat Diseases/surgery , Lymphoma, Non-Hodgkin/veterinary , Animals , Asparaginase/administration & dosage , Cat Diseases/mortality , Cat Diseases/virology , Cats , Cohort Studies , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Female , Leukemia Virus, Feline , Lymphoma, Non-Hodgkin/drug therapy , Lymphoma, Non-Hodgkin/surgery , Male , Methotrexate/administration & dosage , New South Wales , Patient Satisfaction , Prednisolone/administration & dosage , Surveys and Questionnaires , Survival Analysis , Treatment Outcome , Vincristine/administration & dosageABSTRACT
OBJECTIVES: To investigate potential effects of phenobarbitone on the low-dose dexamethasone suppression (LDDS) test and urinary corticoid to creatinine ratio in dogs in a controlled prospective study and in a clinical setting. ANIMALS: Ten crossbreed experimental dogs and 10 client-owned dogs of mixed breeds treated chronically with phenobarbitone to control seizures. PROCEDURES: Experimental dogs were allocated to treatment (6 mg/kg oral phenobarbitone, n = 6) and control (n = 4) groups. LDDS tests (dexamethasone 0.01 mg/kg intravenously, cortisol concentration determined at 0, 2, 4, 6 and 8 h) were conducted repeatedly over a 3-month period. Urinary corticoid to creatinine ratios were measured before LDDS tests. A single LDDS test was performed on 10 epileptic dogs. RESULTS: LDDS and urinary corticoid to creatinine ratios in dogs were not affected by treatment with phenobarbitone. CONCLUSIONS: Phenobarbitone does not interfere with LDDS testing regardless of dosage or treatment time. Urinary corticoid to creatinine ratios are also unaffected.
Subject(s)
Adrenal Cortex Function Tests/veterinary , Adrenal Cortex Hormones/urine , Anticonvulsants/pharmacology , Creatinine/urine , Dexamethasone , Phenobarbital/pharmacology , Animals , Anticonvulsants/blood , Anticonvulsants/therapeutic use , Dexamethasone/blood , Dexamethasone/pharmacokinetics , Dog Diseases/drug therapy , Dogs , Drug Interactions , Female , Hydrocortisone/blood , Male , Phenobarbital/blood , Phenobarbital/therapeutic use , Prospective Studies , Seizures/drug therapy , Seizures/veterinaryABSTRACT
OBJECTIVES: To investigate effects of phenobarbitone on serum activities of alanine aminotransferase, alkaline phosphatase and gamma-glutamyl transferase and concentrations of bilirubin, albumin, cholesterol and total protein in dogs. ANIMALS: Ten crossbreed experimental dogs and 10 client-owned dogs of mixed breeds treated chronically with phenobarbitone to control seizures. PROCEDURES: Experimental dogs were allocated to treatment (6 mg/kg oral phenobarbitone, n = 6) and control (no treatment, n = 4) groups in which serum biochemical tests were performed at intervals during a 3-month period. Biochemical tests were performed once on the 10 epileptic dogs. RESULTS: Phenobarbitone caused increased serum alkaline phosphatase activity but did not affect gamma-glutamyl transferase activity or bilirubin, cholesterol, albumin and total protein concentrations. Phenobarbitone had minimal effect on alanine aminotransferase activity. CONCLUSIONS: Individual dogs treated with phenobarbitone may have small increases in serum alanine aminotransferase activity and variable increases in alkaline phosphatase activity but are unlikely to have alterations in gamma-glutamyl transferase activity or bilirubin, cholesterol, albumin or total protein concentrations.
Subject(s)
Alanine Transaminase/blood , Alkaline Phosphatase/blood , Anticonvulsants/pharmacology , Phenobarbital/pharmacology , Animals , Anticonvulsants/blood , Anticonvulsants/therapeutic use , Bilirubin/blood , Blood Chemical Analysis/veterinary , Blood Proteins/analysis , Cholesterol/blood , Dog Diseases/drug therapy , Dogs , Female , Male , Phenobarbital/blood , Phenobarbital/therapeutic use , Seizures/drug therapy , Seizures/veterinary , Serum Albumin/analysis , gamma-Glutamyltransferase/bloodABSTRACT
A 7-year-old cat was presented for seizures. Cerebrospinal fluid cytology and serology were consistent with a diagnosis of toxoplasmosis. The cat was treated with clindamycin but seizures continued and additional neurological signs developed over 6 months. A mass lesion was identified in the left cerebral hemisphere using magnetic resonance imaging (MRI). The lesion enhanced after gadolidium and a tumour was considered likely. Histologically, the lesion proved to be a cryptococcal granuloma and retrospective serology confirmed that the cat had cryptococcosis at its initial presentation. This report provides the first description in the veterinary literature of the MRI appearance of a cerebral cryptococcoma and emphasises the importance of performing cryptococcal antigen determination in cats with signs of intracranial disease.